Grants paid by Concern Foundation
EIN 23-7002878 · Los Angeles, CA · Form 990, Schedule I · NTEE T22Z
Concern Foundation of Los Angeles, CA (EIN 23-7002878) reported 134 grants paid totaling $4,604,281 to 61 recipients in tax years 2019–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$4,604,281
134 grants
Recipients
61
distinct organizations
Tax years
2019–2024
5 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2019 | 38 | $0 | — |
| 2020 | 35 | $1,132,500 | — |
| 2022 | 17 | $925,000 | — |
| 2023 | 21 | $1,164,781 | — |
| 2024 | 23 | $1,382,000 | — |
Top recipients
The 61 recipients receiving the most from Concern Foundation, by grants paid, out of 61 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Children's Hospital Los Angeles Usc | U | Los Angeles, CA | 3 | $345,000 | 2023 |
| Childrens Hospital Los Angeles 95-1690977 | A | Los Angeles, CA | 4 | $340,000 | 2024 |
| University of Southern California | U | Los Angeles, CA | 5 | $268,500 | 2023 |
| Beckman Research Institute of City of Hope | U | Duarte, CA | 3 | $170,000 | 2023 |
| Usc Norris Comprehensive Cancer Center 95-3798697 | A | Los Angeles, CA | 3 | $150,000 | 2024 |
| The University of Texas Md Anderson Cancer Center 74-6001118 | A | Houston, TX | 2 | $150,000 | 2024 |
| Oregon Health & Science University 23-7083114 | A | Portland, OR | 2 | $150,000 | 2024 |
| Children's Hospital Los Angeles | U | Los Angeles, CA | 6 | $132,500 | 2022 |
| Washington University School of Medicine in St Louis | U | St Louis, MO | 2 | $120,000 | 2023 |
| The University of Illinois at Chicago | U | Chicago, IL | 2 | $120,000 | 2023 |
| University of Michigan | U | Ann Arbor, MI | 2 | $120,000 | 2023 |
| University of Utah 87-6000525 | B | Salt Lake City, UT | 2 | $120,000 | 2023 |
| Brigham and Women's Hospitalharvard Medical School | U | Boston, MA | 2 | $120,000 | 2023 |
| Nyu Grossman School of Medicine | U | New York, NY | 2 | $120,000 | 2023 |
| The Lundquist Institute at Harbor-UCLA Medical Center | U | Torrance, CA | 2 | $120,000 | 2023 |
| University of Southern California 95-1642394 | C | Los Angeles, CA | 1 | $100,000 | 2022 |
| University of Pennsylvania | U | Philadelphia, PA | 7 | $90,000 | 2020 |
| Medical University of South Carolina 57-6028985 | C | Charleston, SC | 6 | $90,000 | 2022 |
| Beauty Bus Foundation 26-3075655 | C | Santa Monica, CA | 4 | $80,000 | 2024 |
| City of Hope Duarte | U | Duarte, CA | 4 | $80,000 | 2020 |
| The Wistar Institute 23-6434390 | A | Philadelphia, PA | 1 | $75,000 | 2024 |
| University of Ca Los Angeles | U | Los Angeles, CA | 3 | $75,000 | 2020 |
| Ohio State University 31-6025986 | A | Columbus, OH | 1 | $75,000 | 2024 |
| Washington University 43-0653611 | A | St Louis, MO | 1 | $75,000 | 2024 |
| Memorial Sloan Kettering Cancer Center 13-1924236 | A | New York, NY | 1 | $75,000 | 2024 |
| Temple University 23-1365971 | A | Philadelphia, PA | 1 | $75,000 | 2024 |
| U-Grow Program Cedars Sinai Medical Center 95-1644600 | A | Los Angeles, CA | 2 | $70,000 | 2024 |
| Cedars Sinai 23-7110551 | D | Los Angeles, CA | 2 | $70,000 | 2023 |
| Purdue University 52-1276063 | B | West Lafayette, IN | 1 | $60,000 | 2022 |
| Purdue University 35-6002041 | B | West Lafayette, IN | 1 | $60,000 | 2023 |
| Sharsheret 13-4198529 | B | Teaneck, NJ | 2 | $50,000 | 2023 |
| Hope for Henry Foundation 20-0244173 | B | Washington, DC | 3 | $42,281 | 2024 |
| American Friends of Hebrew University | U | New York, NY | 3 | $40,000 | 2020 |
| City of Hope | U | Duarte, CA | 2 | $31,000 | 2024 |
| The Regents of the University of California Irvine | U | Irvine, CA | 1 | $30,000 | 2020 |
| Memorial Sloan Kettering Cancer Center New York | U | New York, NY | 3 | $30,000 | 2020 |
| Columbia University NYC 13-1623968 | D | New York, NY | 1 | $30,000 | 2020 |
| Dana-Farber Cancer Institute 04-2263040 | B | Boston, MA | 3 | $30,000 | 2020 |
| Oregon Health & Science University | U | Portland, OR | 1 | $30,000 | 2020 |
| Yale University | U | New Haven, CT | 1 | $30,000 | 2020 |
| Thomas Jefferson University Philadelphia Pa | U | Philadelphia, PA | 3 | $30,000 | 2020 |
| Massachusetts General Hospital 04-1564655 | B | Somerville, MA | 1 | $30,000 | 2020 |
| University of Alabama at Birmingham 58-2040331 | B | Birmingham, AL | 1 | $30,000 | 2020 |
| The Regents of the University of Michigan 38-6006309 | C | Ann Arbor, MI | 1 | $30,000 | 2020 |
| Fred Hutchinson Cancer Research Center 91-1935159 | D | Seattle, WA | 1 | $30,000 | 2020 |
| University of Washington 36-2177139 | D | Chicago, IL | 3 | $30,000 | 2020 |
| Washington State University | U | Pullman, WA | 3 | $30,000 | 2020 |
| Weill Medical College Cornell University | U | New York, NY | 3 | $30,000 | 2020 |
| Beckman Research Institute of the City of Hope | U | Duarte, CA | 1 | $30,000 | 2020 |
| Vanderbilt University 62-0476822 | C | Nashville, TN | 1 | $30,000 | 2020 |
| University of Rochester | U | Rochester, NY | 1 | $30,000 | 2020 |
| Joan & Sanford I Weill Medical College | U | New York, NY | 1 | $30,000 | 2020 |
| University of North Carolina Chapel Hill | U | Chapel Hill, NC | 3 | $30,000 | 2020 |
| University of Ca Irvine | U | Irvine, CA | 3 | $30,000 | 2020 |
| Uscnorris Comprehensive Cancer Center | U | Los Angeles, CA | 3 | $25,000 | 2020 |
| Sharsheret 95-6111928 | A | Los Angeles, CA | 1 | $25,000 | 2024 |
| Chla Summer Oncology | U | Los Angeles, CA | 1 | $25,000 | 2023 |
| Providence | U | Burbank, CA | 1 | $25,000 | 2023 |
| Urologic Health Program Providence St Joseph's Medical Center Disney Famil | U | Burbank, CA | 1 | $25,000 | 2024 |
| Cedars Sinai Medical Ctr | U | Los Angeles, CA | 1 | $20,000 | 2020 |
| Weill Medical College of Cornell | U | New York, NY | 2 | $0 | 2019 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 134 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Childrens Hospital Los Angeles Los Angeles, CA | A | $150,000 | paid | NOVEL MOLECULAR MECHANISM(S) OF P1D1 FUNCTION IN PEDIATRIC BRAIN TUMORS. | 202502889349302375 |
| 2024 | Usc Norris Comprehensive Cancer Center Los Angeles, CA | A | $100,000 | paid | ETHNIC DIFFERENCES IN IMMUNE RESPONSES AMONG BREAST CANCER PATIENTS | 202502889349302375 |
| 2024 | Children's Hospital Los Angeles Los Angeles, CA | A | $90,000 | paid | SUMMER ONCOLOGY RESEARCH FELLOWSHIP PROGRAM | 202502889349302375 |
| 2024 | Children's Hospital Los Angeles Los Angeles, CA | A | $75,000 | paid | ELUCIDATING THE MECHANISM OF CHROMOSOME 17Q GAIN-MEDIATED NEUROBLASTOMA TUMORIGENESIS | 202502889349302375 |
| 2024 | Temple University Philadelphia, PA | A | $75,000 | paid | ROLE OF CHEMOTHERAPY IN PROMOTING AWAKENING OF DORMANT TUMOR CELLS AND METASTATIC RELAPSE | 202502889349302375 |
| 2024 | Oregon Health and Science University Portland, OR | A | $75,000 | paid | REPROGRAMMING SUPPRESSIVE REGULATORY T CELLS IN THE TUMOR MICROENVIRONMENT | 202502889349302375 |
| 2024 | Memorial Sloan Kettering Cancer Center New York, NY | A | $75,000 | paid | EARLY TRANSCRIPTIONAL, EPIGENETIC, AND ENVIRONMENTAL FACTORS OF SQUAMOUS TRANSFORMATION IN LUNG CANCER | 202502889349302375 |
| 2024 | Ohio State University Columbus, OH | A | $75,000 | paid | TARGETING A NEW IMMUNE CHECKPOINT AXIS (PILRCD8) TO TREAT GLIOBLASTOMA | 202502889349302375 |
| 2024 | Washington University St Louis, MO | A | $75,000 | paid | TARGETING MECHANISMS OF TUMOR IMMUNE EVASION IN CERVICAL CANCER | 202502889349302375 |
| 2024 | The University of Texas Md Anderson Cancer Center Houston, TX | A | $75,000 | paid | TARGETING COLLAGEN I HOMOTRIMER INDUCED IL-18 AS A NOVEL THERAPEUTIC STRATEGY IN PANCREATIC CANCER | 202502889349302375 |
| 2024 | Oregon Health & Science University Portland, OR | A | $75,000 | paid | ANTIGEN SORTING BY DENDRITIC CELLS IMPACTS ANTI-TUMOR IMMUNITY | 202502889349302375 |
| 2024 | Ut Md Anderson Cancer Center Houston, TX | A | $75,000 | paid | ELUCIDATING THE MOLECULAR AND CELLULAR PATHOGENESIS OF ENDOGENOUS RETROVIRUSES IN SKIN CANCER | 202502889349302375 |
| 2024 | The Wistar Institute Philadelphia, PA | A | $75,000 | paid | MYELOID CELL-DERIVED INTERLEUKIN 1B PROMOTES CHEMORESISTANCE IN METASTATIC OVARIAN CANCER. | 202502889349302375 |
| 2024 | U-Grow Program Cedars Sinai Medical Center Los Angeles, CA | A | $50,000 | paid | FOR THE U GROW PROGRAM PREPARING FUTURE SCIENTISTS FOR GRADUATE SCHOOL | 202502889349302375 |
| 2024 | Beauty Bus Foundation Los Angeles, CA | A | $45,000 | paid | POP-UP EVENTS FOR THE CANCER COMMUNITY | 202502889349302375 |
| 2024 | Hope for Henry Foundation Washington, DC | A | $30,000 | paid | TO EXPAND THE HOPE FOR HENRYS HIGH-IMPACT AND IN-DEMAND SUPER REWARDS FOR SUPER KIDS PROGRAM TO ONE NEW HOSPITAL. | 202502889349302375 |
| 2024 | Children's Hospital Los Angeles Los Angeles, CA | A | $25,000 | paid | EVALUATION OF A NOVEL CELLULAR THERAPY FOR CHILDREN AND YOUNG ADOLESCENTS WITH HIGH-GRADE GLIOMA BRAIN TUMORS | 202502889349302375 |
| 2024 | Sharsheret Los Angeles, CA | A | $25,000 | paid | TO COVER BUSY BOX AND THRIVING AGAIN KITS | 202502889349302375 |
| 2024 | Usc Norris Head & Neck Cancer Los Angeles, CA | A | $25,000 | paid | TO SUPPORT A NOVEL HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) IMMUNOTHERAPY STUDY USING BOTH ANIMAL MODELS AND PATIENT-DERIVED TUMOR ORGANOIDS | 202502889349302375 |
| 2024 | Urologic Health Program Providence St Joseph's Medical Center Disney Famil Burbank, CA | U | $25,000 | paid | TO COVER UROLOGIC ONCOLOGY PROGRAMS AT THE DISNEY CANCER CENTER | 202502889349302375 |
| 2024 | Usc Norris Comprehensive Cancer Center Los Angeles, CA | A | $25,000 | paid | TO EXPAND THE ADOLESCENT AND YOUNG ADULT CANCER PROGRAM AT USC | 202502889349302375 |
| 2024 | City of Hope Duarte, CA | U | $22,000 | paid | PANCREATIC DUCTAL ADENOCARCINOMA- COLLECTING PLASMA WITH PANCREATIC CANCER AND THOSE IN HIGH RISK OF DEVELOPING THE DISEASE | 202502889349302375 |
| 2024 | Cedars Sinai Medical Center Los Angeles, CA | A | $20,000 | paid | TO COVER SERVICES AND WORKSHOPS FOR THE WELLNESS, RESILIENCE, AND SURVIVORSHIP PROGRAM | 202502889349302375 |
| 2023 | Children's Hospital Los Angeles Usc Los Angeles, CA | U | $225,000 | paid | FLIP-FLOPPING OF FUSION-POSITIVE RHABDOMYOSARCOMA LEADING TO METASTATIC INVASION | 202432969349301333 |
| 2023 | University of Southern California Los Angeles, CA | U | $100,000 | paid | ETHNIC DIFFERENCES AMONG BREAST CANCER PATIENT IMMUNE RESPONSES | 202432969349301333 |
| 2023 | The Lundquist Institute at Harbor-UCLA Medical Center Torrance, CA | U | $60,000 | paid | INVESTIGATING NOVEL SIGNALING CIRCUITS CONTROLLING PDL1 SURFACE LOCALIZATION IN CANCER CELLS. | 202432969349301333 |
| 2023 | University of Utah Salt Lake City, UT | B | $60,000 | paid | TENASCIN-C IN EARLY LUNG CANCER INVASION | 202432969349301333 |
| 2023 | University of Michigan Ann Arbor, MI | U | $60,000 | paid | REGULATING JAK-STAT SIGNALING PATHWAYS TO ENHANCE T CELL IMMUNOTHERAPY | 202432969349301333 |
| 2023 | Children's Hospital Los Angeles Usc Los Angeles, CA | U | $60,000 | paid | FLIP-FLOPPING OF FUSION-POSITIVE RHABDOMYOSARCOMA LEADING TO METASTATIC INVASION | 202432969349301333 |
| 2023 | Nyu Grossman School of Medicine NY, NY | U | $60,000 | paid | DISCOVERING AND TARGETING COQ10 SYNTHESIS IN PANCREATIC CANCER | 202432969349301333 |
| 2023 | University of Southern California Los Angeles, CA | U | $60,000 | paid | EXPANSION OF THE ADOLESCENT AND YOUNG ADULT CANCER PROGRAM AT USC | 202432969349301333 |
| 2023 | Purdue University West Lafayette, IN | B | $60,000 | paid | THE ROLE OF PP2A IN REGULATING PDAC METHUOSIS | 202432969349301333 |
| 2023 | Beckman Research Institute of City of Hope Duarte, CA | U | $60,000 | paid | TARGETING THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IN B CELL MALIGNANCIES | 202432969349301333 |
| 2023 | Brigham and Women's Hospitalharvard Medical School Boston, MA | U | $60,000 | paid | OVERCOMING PARP INHIBITOR RESISTANCE BY MODULATING TUMOR ASSOCIATED MACROPHAGES TO ENHANCE T CELL ACTIVATION | 202432969349301333 |
| 2023 | Washington University School of Medicine in St Louis St Louis, MO | U | $60,000 | paid | INVESTIGATE THE TUMOR SUPPRESSIVE ROLE OF ARID HOMOLOGS IN MELANOMA | 202432969349301333 |
| 2023 | The University of Illinois at Chicago Chicago, IL | U | $60,000 | paid | REGULATION OF MECHANOSURVEILLANCE BY K HANDLING DURING BREAST CANCER METASTASIS | 202432969349301333 |
| 2023 | Cedars Sinai Los Angeles, CA | D | $50,000 | paid | U-GROW PROGRAM | 202432969349301333 |
| 2023 | Providence Burbank, CA | U | $25,000 | paid | UROLOGIC ONCOLOGY PROGRAMS AT THE DISNEY CANCER CENTER | 202432969349301333 |
| 2023 | Sharsheret Teaneck, NJ | B | $25,000 | paid | BUSY BOX AND THRIVING AGAIN KITS | 202432969349301333 |
| 2023 | Chla Summer Oncology Los Angeles, CA | U | $25,000 | paid | SUMMER ONCOLOGY RESEARCH FELLOWSHIP | 202432969349301333 |
| 2023 | University of Southern California Los Angeles, CA | U | $23,500 | paid | EXPANSION OF THE ADOLESCENT AND YOUNG ADULT CANCER PROGRAM AT USC | 202432969349301333 |
| 2023 | Cedars Sinai Los Angeles, CA | D | $20,000 | paid | WELLNESS, RESILIENCE, AND SURVIVORSHIP PROGRAM | 202432969349301333 |
| 2023 | City of Hope Duarte, CA | U | $9,000 | paid | PANCREATIC DUCTAL ADENOCARCINOMA- COLLECTING PLASMA WITH PANCREATIC CANCER AND THOSE IN HIGH RISK OF DEVELOPING THE DISEASE | 202432969349301333 |
| 2023 | Hope for Henry Washington, DC | C | $2,281 | paid | EXPANSION OF THE HOPE FOR HENRYS HIGH-IMPACT AND IN-DEMAND SUPER REWARDS FOR SUPER KIDS PROGRAM TO ONE NEW HOSPITAL | 202432969349301333 |
| 2022 | University of Southern California Los Angeles, CA | C | $100,000 | paid | RESEARCH INTO ETHNIC DIFFERENCES AMONG BREAST CANCER PATIENT IMMUNE RESPONSES | 202332429349301353 |
| 2022 | University of Utah Salt Lake City, UT | B | $60,000 | paid | TENASCIN-C IN EARLY LUNG CANCER INVASION | 202332429349301353 |
| 2022 | The Lundquist Institute at Harbor-UCLA Medical Center Torrance, CA | U | $60,000 | paid | INVESTIGATING NOVEL SIGNALING CIRCUITS CONTROLLING PDL1 SURFACE LOCALIZATION IN CANCER CELLS. | 202332429349301353 |
| 2022 | Beckman Research Institute of City of Hope Duarte, CA | U | $60,000 | paid | TARGETING THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IN B CELL MALIGNANCIES | 202332429349301353 |
| 2022 | University of Michigan Ann Arbor, MI | U | $60,000 | paid | REGULATING JAK-STAT SIGNALING PATHWAYS TO ENHANCE T CELL IMMUNOTHERAPY | 202332429349301353 |
| 2022 | Purdue University West Lafayette, IN | B | $60,000 | paid | THE ROLE OF PP2A IN REGULATING PDAC METHUOSIS | 202332429349301353 |
| 2022 | Medical University of South Carolina Charleston, SC | C | $60,000 | paid | KRASG12R ALLELE-SPECIFIC METABOLIC REPROGRAMMING ALTERS THERAPEUTIC SENSITIVITY | 202332429349301353 |
| 2022 | The University of Illinois at Chicago Chicago, IL | U | $60,000 | paid | REGULATION OF MECHANOSURVEILLANCE BY K HANDLING DURING BREAST CANCER METASTASIS | 202332429349301353 |
| 2022 | Brigham and Women's Hospitalharvard Medical School Boston, MA | U | $60,000 | paid | OVERCOMING PARP INHIBITOR RESISTANCE BY MODULATING TUMOR ASSOCIATED MACROPHAGES TO ENHANCE T CELL ACTIVATION | 202332429349301353 |
| 2022 | Washington University School of Medicine in St Louis St Louis, MO | U | $60,000 | paid | INVESTIGATE THE TUMOR SUPPRESSIVE ROLE OF ARID HOMOLOGS IN MELANOMA | 202332429349301353 |
| 2022 | Nyu Grossman School of Medicine New York, NY | U | $60,000 | paid | DISCOVERING AND TARGETING COQ10 SYNTHESIS IN PANCREATIC CANCER | 202332429349301353 |
| 2022 | Children's Hospital Los Angeles Usc Los Angeles, CA | U | $60,000 | paid | FLIP-FLOPPING OF FUSION-POSITIVE RHABDOMYOSARCOMA LEADING TO METASTATIC INVASION | 202332429349301353 |
| 2022 | University of Southern California Los Angeles, CA | U | $55,000 | paid | LIQUID BIOPSY DATABASE CREATION | 202332429349301353 |
| 2022 | Beckman Research Institute of City of Hope Duarte, CA | U | $50,000 | paid | DISRUPTING METABOLIC ADAPTATION IN PANCREATIC CANCER THROUGH INTRATUMORAL HEPARAN SULFATE DEGRADATIOR | 202332429349301353 |
| 2022 | Sharsheret Teaneck, NJ | B | $25,000 | paid | QUALITY OF LIFE KITS AND THE BUSY BOXES | 202332429349301353 |
| 2022 | Children's Hospital Los Angeles Los Angeles, CA | U | $25,000 | paid | SUMMER STUDENT ONCOLOGY PROGRAM | 202332429349301353 |
| 2022 | Hope for Henry Foundation Washington, DC | B | $10,000 | paid | SUPER REWARDS FOR SUPER KIDS AT CHLA | 202332429349301353 |
| 2020 | Children's Hospital Los Angeles Los Angeles, CA | U | $87,500 | paid | Novel Molecular Mechanisms of P1D1 function in Pediatric Brain Tumors | 202143149349301639 |
| 2020 | University of Ca Los Angeles Los Angeles, CA | U | $75,000 | paid | Identification and Functional Characterization of Kinases Driving Prostate Cancer Metastasis to Bone. | 202143149349301639 |
| 2020 | City of Hope Duarte Duarte, CA | U | $50,000 | paid | Phase I/II Study Combining Chemotherapy, AKT3 Targeted Therapy, and Immune Checkpoint Inhibitors in Patients with Metastatic Triple Negative Breast Cancer | 202143149349301639 |
| 2020 | American Friends of Hebrew University New York, NY | U | $40,000 | paid | Year Two of Seven Young Research Professorship at The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Jerusalem Israel. | 202143149349301639 |
| 2020 | Beauty Bus Foundation Santa Monica, CA | C | $35,000 | paid | Patients and Caregivers Psychosocial support | 202143149349301639 |
| 2020 | Columbia University NYC New York, NY | D | $30,000 | paid | Role of Histone Methyltransferase NSD1 in Squamous Cell Carcinoma Immune Evasion | 202143149349301639 |
| 2020 | Medical University of South Carolina Charleston, SC | C | $30,000 | paid | The Adherens Junctions orchestrate a tumor suppressing program via RNAi | 202143149349301639 |
| 2020 | University of Pennsylvania Philadelphia, PA | U | $30,000 | paid | Towards understanding and targeting transcriptional addiction in advanced prostate cancer | 202143149349301639 |
| 2020 | University of Alabama at Birmingham Birmingham, AL | B | $30,000 | paid | A Transcriptional Vulnerability in Acute Myeloid Leukemia | 202143149349301639 |
| 2020 | University of Ca Irvine Irvine, CA | U | $30,000 | paid | Circadian Sphingosine Signaling mediates Tumor/Host Crosstalk | 202143149349301639 |
| 2020 | Thomas Jefferson University Philadelphia Pa Philadelphia, PA | U | $30,000 | paid | Deciphering Non-Coding RNA Signaling in Acute Myeloid Leukemia | 202143149349301639 |
| 2020 | University of Washington Chicago, IL | D | $30,000 | paid | Modeling intratumoral heterogeneity in glioblastoma using brain organoids | 202143149349301639 |
| 2020 | University of Rochester Rochester, NY | U | $30,000 | paid | Mechanisms underlying Neat1 function in preserving the identity of pancreatic cells | 202143149349301639 |
| 2020 | Memorial Sloan Kettering Cancer Center New York New York, NY | U | $30,000 | paid | p53-driven a-ketoglutarate accumulation promotes tumor suppression | 202143149349301639 |
| 2020 | Massachusetts General Hospital Somerville, MA | B | $30,000 | paid | Targeting Fatty acid biosynthesis in Glioblastoma | 202143149349301639 |
| 2020 | City of Hope Duarte Duarte, CA | U | $30,000 | paid | Targeting Metabolic Pathways in Breast Cancer | 202143149349301639 |
| 2020 | Weill Medical College Cornell University New York, NY | U | $30,000 | paid | Targeting cancer-specific vulnerabilities in the WNT pathway | 202143149349301639 |
| 2020 | Vanderbilt University Nashville, TN | C | $30,000 | paid | Radiation-Induced Pre-Metastatic Niche Formation in Breast Cancer Recurrence | 202143149349301639 |
| 2020 | University of Pennsylvania Philadelphia, PA | U | $30,000 | paid | Notch-driven Epigenetic Program of Triple-Negative Breast Cancer | 202143149349301639 |
| 2020 | Washington State University Pullman, WA | U | $30,000 | paid | Dissecting stromal signals to target prostate cancer microenvironment | 202143149349301639 |
| 2020 | Joan & Sanford I Weill Medical College New York, NY | U | $30,000 | paid | Determining the role and regulation of de novo NADP synthesis in melanoma metastasis | 202143149349301639 |
| 2020 | Yale University New Haven, CT | U | $30,000 | paid | Connecting Cysteine Oxidation to Cancer Cell Signaling in Infection-associated Cancers | 202143149349301639 |
| 2020 | Fred Hutchinson Cancer Research Center Seattle, WA | D | $30,000 | paid | Targeting Developmental Circuits for Immune Re-programming | 202143149349301639 |
| 2020 | The Regents of the University of Michigan Ann Arbor, MI | C | $30,000 | paid | Role of Hypoxia in B cell Migration and Function in Pancreatic Cancer | 202143149349301639 |
| 2020 | University of Pennsylvania Philadelphia, PA | U | $30,000 | paid | Targeting tumor-infiltrating antigen presenting cells for immunotherapy | 202143149349301639 |
| 2020 | The Regents of the University of California Irvine Irvine, CA | U | $30,000 | paid | APOBEC3A REGULATION IN CANCER BY THE DNA DAMAGE RESPONSE | 202143149349301639 |
| 2020 | University of North Carolina Chapel Hill Chapel Hill, NC | U | $30,000 | paid | Role of IL35 in immunotherapy resistance in pancreatic cancer | 202143149349301639 |
| 2020 | Beckman Research Institute of the City of Hope Duarte, CA | U | $30,000 | paid | The role of CEACAM1 in oncogenic B-cell receptor signaling in mantle cell lymphoma | 202143149349301639 |
| 2020 | Oregon Health & Science University Portland, OR | U | $30,000 | paid | Mechanisms of kinase inhibitor resistance in Chronic Neutrophilic Leukemia | 202143149349301639 |
| 2020 | University of Southern California Los Angeles, CA | U | $30,000 | paid | Optimizing immunotherapy by reprogramming the suppressive tumor microenvironment of breast cancer | 202143149349301639 |
| 2020 | Dana-Farber Cancer Institute Boston, MA | B | $30,000 | paid | Mechanism of human cGASDNA recognition and antitumor immune activation | 202143149349301639 |
| 2020 | Uscnorris Comprehensive Cancer Center Los Angeles, CA | U | $25,000 | paid | Germ Cell Tumors Study | 202143149349301639 |
| 2020 | Cedars Sinai Medical Ctr Los Angeles, CA | U | $20,000 | paid | Cedars-Sinai Cancer Wellness, Resilience, and Survivorship Programs | 202143149349301639 |
| 2020 | Children's Hospital Los Angeles Los Angeles, CA | U | $10,000 | paid | Summer Student Oncology Program | 202143149349301639 |
| 2020 | Children's Hospital Los Angeles Los Angeles, CA | U | $10,000 | paid | Clinical Course and Immune Responses in COVID-19 in Children and Young Adults with Cancer | 202143149349301639 |
| 2019 | Medical University of South Carolina Charleston, SC | C | $0 + $60,000 non-cash | paid | THE ADHERENS JUNCTIONS ORCHESTRATE A TUMOR SUPPRESSING PROGRAM VIA RNAI | 202023189349309887 |
| 2019 | Medical University of South Carolina Charleston, SC | C | $0 + $60,000 non-cash | paid | THE ADHERENS JUNCTIONS ORCHESTRATE A TUMOR SUPPRESSING PROGRAM VIA RNAI | 202023189349309887 |
| 2019 | Weill Medical College of Cornell New York, NY | U | $0 + -$160 non-cash | paid | RETURN OF UNUSED GRANT MONEY FROM DR. ZEYNEP GUMUS 2010-2012 GRANT CYCLE | 202023189349309887 |
| 2019 | Weill Medical College of Cornell New York, NY | U | $0 + -$160 non-cash | paid | RETURN OF UNUSED GRANT MONEY FROM DR. ZEYNEP GUMUS 2010-2012 GRANT CYCLE | 202023189349309887 |
| 2019 | University of North Carolina Chapel Hill Chapel Hill, NC | U | $0 + $60,000 non-cash | paid | ROLE OF IL35 IN IMMUNOTHERAPY RESISTANCE IN PANCREATIC CANCER | 202023189349309887 |
| 2019 | University of North Carolina Chapel Hill Chapel Hill, NC | U | $0 + $60,000 non-cash | paid | ROLE OF IL35 IN IMMUNOTHERAPY RESISTANCE IN PANCREATIC CANCER | 202023189349309887 |
| 2019 | Weill Medical College Cornell University New York, NY | U | $0 + $60,000 non-cash | paid | TARGETING CANCER-SPECIFIC VULNERABILITIES IN THE WNT PATHWAY | 202023189349309887 |
| 2019 | Weill Medical College Cornell University New York, NY | U | $0 + $60,000 non-cash | paid | TARGETING CANCER-SPECIFIC VULNERABILITIES IN THE WNT PATHWAY | 202023189349309887 |
| 2019 | Beauty Bus Foundation Santa Monica, CA | C | $0 + $35,000 non-cash | paid | PATIENTS AND CAREGIVERS PSYCHOSOCIAL SUPPORT | 202023189349309887 |
| 2019 | Beauty Bus Foundation Santa Monica, CA | C | $0 + $35,000 non-cash | paid | PATIENTS AND CAREGIVERS PSYCHOSOCIAL SUPPORT | 202023189349309887 |
| 2019 | University of Washington Chicago, IL | D | $0 + $60,000 non-cash | paid | MODELING INTRATUMORAL HETEROGENEITY IN GLIOBLASTOMA USING BRAIN ORGANOIDS | 202023189349309887 |
| 2019 | University of Washington Chicago, IL | D | $0 + $60,000 non-cash | paid | MODELING INTRATUMORAL HETEROGENEITY IN GLIOBLASTOMA USING BRAIN ORGANOIDS | 202023189349309887 |
| 2019 | Medical University of South Carolina Charleston, SC | C | $0 + -$286 non-cash | paid | RETURN OF UNUSED GRANT FUNDS FROM DR. ELIZABETH YEH 2016-2018 GRANT CYCLE | 202023189349309887 |
| 2019 | Medical University of South Carolina Charleston, SC | C | $0 + -$286 non-cash | paid | RETURN OF UNUSED GRANT FUNDS FROM DR. ELIZABETH YEH 2016-2018 GRANT CYCLE | 202023189349309887 |
| 2019 | Children's Hospital Los Angeles Los Angeles, CA | U | $0 + $60,000 non-cash | paid | NOVEL MOLECULAR MECHANISM(S) OF P1D1 FUNCTION IN PEDIATRIC BRAIN TUMORS | 202023189349309887 |
| 2019 | Children's Hospital Los Angeles Los Angeles, CA | U | $0 + $60,000 non-cash | paid | NOVEL MOLECULAR MECHANISM(S) OF P1D1 FUNCTION IN PEDIATRIC BRAIN TUMORS | 202023189349309887 |
| 2019 | Uscnorris Comprehensive Cancer Center Los Angeles, CA | U | $0 + $80,000 non-cash | paid | AYA SARCOMA STUDY: RHABDOMYOSARCOMA | 202023189349309887 |
| 2019 | Uscnorris Comprehensive Cancer Center Los Angeles, CA | U | $0 + $80,000 non-cash | paid | AYA SARCOMA STUDY: RHABDOMYOSARCOMA | 202023189349309887 |
| 2019 | Washington State University Pullman, WA | U | $0 + $60,000 non-cash | paid | DISSECTING STROMAL SIGNALS TO TARGET PROSTATE CANCER MICROENVIRONMENT | 202023189349309887 |
| 2019 | Washington State University Pullman, WA | U | $0 + $60,000 non-cash | paid | DISSECTING STROMAL SIGNALS TO TARGET PROSTATE CANCER MICROENVIRONMENT | 202023189349309887 |
| 2019 | University of Pennsylvania Philadelphia, PA | U | $0 + $60,000 non-cash | paid | NOTCH-DRIVEN EPIGENETIC PROGRAM OF TRIPLE-NEGATIVE BREAST CANCER | 202023189349309887 |
| 2019 | University of Pennsylvania Philadelphia, PA | U | $0 + $60,000 non-cash | paid | NOTCH-DRIVEN EPIGENETIC PROGRAM OF TRIPLE-NEGATIVE BREAST CANCER | 202023189349309887 |
| 2019 | University of Ca Los Angeles Los Angeles, CA | U | $0 + $100,000 non-cash | paid | IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF KINASES DRIVING PROSTATE CANCER METASTASIS TO BONE. | 202023189349309887 |
| 2019 | University of Ca Los Angeles Los Angeles, CA | U | $0 + $100,000 non-cash | paid | IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF KINASES DRIVING PROSTATE CANCER METASTASIS TO BONE. | 202023189349309887 |
| 2019 | Thomas Jefferson University Philadelphia Pa Philadelphia, PA | U | $0 + $60,000 non-cash | paid | DECIPHERING NON-CODING RNA SIGNALING IN ACUTE MYELOID LEUKEMIA | 202023189349309887 |
| 2019 | Thomas Jefferson University Philadelphia Pa Philadelphia, PA | U | $0 + $60,000 non-cash | paid | DECIPHERING NON-CODING RNA SIGNALING IN ACUTE MYELOID LEUKEMIA | 202023189349309887 |
| 2019 | American Friends of Hebrew University New York, NY | U | $0 + $40,000 non-cash | paid | YEAR ONE OF SEVEN YOUNG RESEARCH PROFESSORSHIP AT THE CONCERN FOUNDATION LABORATORIES AT THE LAUTENBERG CENTER FOR IMMUNOLOGY AND CANCER RESEARCH, JERUSALEM ISRAEL. | 202023189349309887 |
| 2019 | American Friends of Hebrew University New York, NY | U | $0 + $40,000 non-cash | paid | YEAR ONE OF SEVEN YOUNG RESEARCH PROFESSORSHIP AT THE CONCERN FOUNDATION LABORATORIES AT THE LAUTENBERG CENTER FOR IMMUNOLOGY AND CANCER RESEARCH, JERUSALEM ISRAEL. | 202023189349309887 |
| 2019 | University of Pennsylvania Philadelphia, PA | U | $0 + $60,000 non-cash | paid | TARGETING TUMOR-INFILTRATING ANTIGEN PRESENTING CELLS FOR IMMUNOTHERAPY | 202023189349309887 |
| 2019 | University of Pennsylvania Philadelphia, PA | U | $0 + $60,000 non-cash | paid | TARGETING TUMOR-INFILTRATING ANTIGEN PRESENTING CELLS FOR IMMUNOTHERAPY | 202023189349309887 |
| 2019 | University of Ca Irvine Irvine, CA | U | $0 + $60,000 non-cash | paid | CIRCADIAN SPHINGOSINE SIGNALING MEDIATES TUMOR/HOST CROSSTALK | 202023189349309887 |
| 2019 | University of Ca Irvine Irvine, CA | U | $0 + $60,000 non-cash | paid | CIRCADIAN SPHINGOSINE SIGNALING MEDIATES TUMOR/HOST CROSSTALK | 202023189349309887 |
| 2019 | Memorial Sloan Kettering Cancer Center New York New York, NY | U | $0 + $60,000 non-cash | paid | P53-DRIVEN A-KETOGLUTARATE ACCUMULATION PROMOTES TUMOR SUPPRESSION | 202023189349309887 |
| 2019 | Memorial Sloan Kettering Cancer Center New York New York, NY | U | $0 + $60,000 non-cash | paid | P53-DRIVEN A-KETOGLUTARATE ACCUMULATION PROMOTES TUMOR SUPPRESSION | 202023189349309887 |
| 2019 | Dana-Farber Cancer Institute Boston, MA | B | $0 + $60,000 non-cash | paid | MECHANISM OF HUMAN CGASDNA RECOGNITION AND ANTITUMOR IMMUNE ACTIVATION | 202023189349309887 |
| 2019 | Dana-Farber Cancer Institute Boston, MA | B | $0 + $60,000 non-cash | paid | MECHANISM OF HUMAN CGASDNA RECOGNITION AND ANTITUMOR IMMUNE ACTIVATION | 202023189349309887 |
| 2019 | City of Hope Duarte Duarte, CA | U | $0 + $60,000 non-cash | paid | TARGETING METABOLIC PATHWAYS IN BREAST CANCER | 202023189349309887 |
| 2019 | City of Hope Duarte Duarte, CA | U | $0 + $60,000 non-cash | paid | TARGETING METABOLIC PATHWAYS IN BREAST CANCER | 202023189349309887 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202502889349302375 |
| 990 | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202432969349301333 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202332429349301353 |
| 990 | 2020 | 2020-12-31 | not stated | 2020v4.1 | 202143149349301639 |
| 990 | 2019 | 2019-12-31 | not stated | 2019v5.1 | 202023189349309887 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/237002878.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.